CD4 and neoplasm: We next performed IHC immunostaining for several established markers of distinct immune subclasses in human MPNST tumor tissue, including CD45 (pan-leukocyte), CD3 (T cells, CD4+ and CD8+ subsets), CD68 (macrophages/monocytes), and CD20 (B cells).